Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
27.20
-1.55 (-5.39%)
At close: Apr 28, 2026, 4:00 PM EDT
27.36
+0.16 (0.59%)
After-hours: Apr 28, 2026, 4:17 PM EDT
Tectonic Therapeutic Market Cap
Tectonic Therapeutic has a market cap or net worth of $510.72 million as of April 28, 2026. Its market cap has increased by 64.07% in one year.
Market Cap
510.72M
Enterprise Value
284.68M
1-Year Change
64.07%
Ranking
Category
Stock Price
$27.20
Market Cap Chart
Since June 21, 2024, Tectonic Therapeutic's market cap has increased from $250.63M to $510.72M, an increase of 103.78%. That is a compound annual growth rate of 46.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 539.83M | 38.27% |
| Dec 31, 2025 | 390.42M | -42.68% |
| Dec 31, 2024 | 681.13M | 171.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rigel Pharmaceuticals | 559.76M |
| Altimmune | 553.47M |
| Sutro Biopharma | 552.19M |
| Kyverna Therapeutics | 548.40M |
| AgomAb Therapeutics NV | 538.54M |
| enGene Therapeutics | 535.25M |
| Lyell Immunopharma | 522.79M |
| Eikon Therapeutics | 522.71M |